Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains
I'm PortAI, I can summarize articles.
Novavax Inc. shares rose 1.20% to $6.74 on Wednesday, ending a two-day losing streak. Despite gains, the stock underperformed compared to competitors like Johnson & Johnson, Pfizer, and Merck. Novavax remains 41.65% below its 52-week high of $11.55. The NASDAQ Composite Index and Dow Jones Industrial Average also saw gains.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments